People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Qrxpharma Ltd | — | Pharmaceuticals | Series A | $12.4M | $384.0M | 2009 |
Peter W. Farrell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter W. Farrell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John W. Holaday | 1 | 3 |
| Gary W. Pace | 1 | 3 |
| Warren W. Stern | 1 | 1 |
| Chris W. Campbell | 1 | 1 |
| Michael W. Quinn | 1 | 1 |
| Peter W. Campbell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.